- Home
- BLUE vs PULM Comparison
BLUE vs PULM Comparison
Compare BLUE & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLUE
- PULM
- Stock Information
- Founded
- BLUE 1992
- PULM 2003
- Country
- BLUE United States
- PULM United States
- Employees
- BLUE N/A
- PULM N/A
- Industry
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- BLUE Health Care
- PULM Health Care
- Exchange
- BLUE Nasdaq
- PULM Nasdaq
- Market Cap
- BLUE 36.9M
- PULM 30.9M
- IPO Year
- BLUE 2013
- PULM N/A
- Fundamental
- Price
- BLUE $4.98
- PULM $6.12
- Analyst Decision
- BLUE Hold
- PULM
- Analyst Count
- BLUE 7
- PULM 0
- Target Price
- BLUE $44.60
- PULM N/A
- AVG Volume (30 Days)
- BLUE 750.4K
- PULM 9.0K
- Earning Date
- BLUE 05-20-2025
- PULM 05-27-2025
- Dividend Yield
- BLUE N/A
- PULM N/A
- EPS Growth
- BLUE N/A
- PULM N/A
- EPS
- BLUE N/A
- PULM N/A
- Revenue
- BLUE $83,807,000.00
- PULM $7,806,000.00
- Revenue This Year
- BLUE $218.58
- PULM N/A
- Revenue Next Year
- BLUE N/A
- PULM $134.88
- P/E Ratio
- BLUE N/A
- PULM N/A
- Revenue Growth
- BLUE 184.12
- PULM 6.96
- 52 Week Low
- BLUE $3.56
- PULM $1.72
- 52 Week High
- BLUE $28.60
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- BLUE 63.73
- PULM 45.47
- Support Level
- BLUE $3.20
- PULM $5.98
- Resistance Level
- BLUE $4.45
- PULM $6.68
- Average True Range (ATR)
- BLUE 0.20
- PULM 0.34
- MACD
- BLUE 0.04
- PULM 0.01
- Stochastic Oscillator
- BLUE 99.44
- PULM 24.74
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.